EcoDrugPlus

Plasminogen Activator, Tissue Type

Ensembl ID : ENSTRUG00000016380
Gene Symbol: PLAT
3 Cross references
205 Possible Orthologues:

Platelet Activating Factor Receptor

Ensembl ID : ENSTRUG00000030536
Gene Symbol: PTAFR
2 Cross references
223 Possible Orthologues:

Platelet Activating Factor Receptor

Ensembl ID : ENSTRUG00000026899
Gene Symbol: PTAFR
1 Cross references
223 Possible Orthologues:

Platelet Derived Growth Factor Receptor Alpha

Ensembl ID : ENSTRUG00000015076
Gene Symbol: PDGFRA
3 Cross references
204 Possible Orthologues:

Platelet Derived Growth Factor Receptor Beta

Ensembl ID : ENSTRUG00000007528
Gene Symbol: PDGFRB
3 Cross references
198 Possible Orthologues:

Platelet Derived Growth Factor Subunit B

Ensembl ID : ENSTRUG00000022420
Gene Symbol: PDGFB
2 Cross references
190 Possible Orthologues:

Platelet-Derived Growth Factor Receptor Beta-Like

Ensembl ID : ENSTRUG00000004733
Gene Symbol: LOC101061130
2 Cross references
174 Possible Orthologues:

Polo Like Kinase 4

Ensembl ID : ENSTRUG00000007503
Gene Symbol: PLK4
4 Cross references
215 Possible Orthologues:

Poly (Adp-Ribose) Polymerase Family, Member 3

Ensembl ID : ENSTRUG00000032127
Gene Symbol: PARP3
1 Cross references
195 Possible Orthologues:

Poly(Adp-Ribose) Polymerase 1

Ensembl ID : ENSTRUG00000014490
Gene Symbol: PARP1
4 Cross references
209 Possible Orthologues:

Poly(Adp-Ribose) Polymerase 2

Ensembl ID : ENSTRUG00000010876
Gene Symbol: PARP2
3 Cross references
185 Possible Orthologues:

Poly(Adp-Ribose) Polymerase Family Member 3

Ensembl ID : ENSTRUG00000002578
Gene Symbol: PARP3
3 Cross references
154 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).